Skip to main content

Table 1 Prevalence of hybrid capture 2 positive-women by age and recruitment centre

From: Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial

HPV+/Tested women (prevalence%)

Age groups

25-29

30-34

35-39

40-44

45-49

50-54

55-60

Total

Verona

69/587 (11.8%)

104/736 (14.1%)

62/632 (9.8%)

43/533 (8.1%)

28/322 (8.7%)

37/476 (7.8%)

20/449 (4.5%)

363/3735 (9.7%)

Padua

142/994 (14.3%)

124/1013 (12.2%)

134/948 (14.1%)

59/799 (7.4%)

33/551 (6.0%)

10/262 (3.8%)

13/723 (1.8%)

515/5290 (9.7%)

Ravenna

65/340 (19.1%)

67/521 (12.9%)

68/591 (11.5%)

43/628 (6.8%)

36/582 (6.2%)

31/548 (5.7%)

38/541 (7.0%)

348/3751 (9.3%)

Florence

150/926 (16.2%)

141/1045 (13.5%)

138/1277 (10.8%)

103/1306 (7.9%)

90/1227 (7.3%)

58/1204 (4.8%)

48/1129 (4.3%)

728/8114 (9.0%)

Imola

58/325 (17.8%)

50/415 (12.0%)

48/528 (9.1%)

41/510 (8.0%)

28/373 (7.5%)

17/406 (4.2%)

17/357 (4.8%)

259/2914 (8.9%)

Turin

274/1761 (15.6%)

252/1909 (13.2%)

166/2219 (7.5%)

132/2142 (6.2%)

99/1860 (5.3%)

99/1904 (5.2%)

84/2015 (4.2%)

1106/13810 (8.0%)

Bologna

28/137 (20.4%)

29/262 (11.1%)

43/418 (10.3%)

35/480 (7.3%)

24/413 (5.8%)

22/432 (5.1%)

16/428 (3.7%)

197/2570 (7.7%)

Viterbo

71/507 (14.0%)

35/390 (9.0%)

36/501 (7.2%)

27/460 (5.9%)

34/440 (7.7%)

17/376 (4.5%)

14/415 (3.4%)

234/3089 (7.6%)

Trento

43/400 (10.8%)

41/572 (7.2%)

39/634 (6.2%)

34/632 (5.4%)

22/501 (4.4%)

16/459 (3.5%)

12/429 (2.8%)

207/3627 (5.7%)

Total

900/5977 (15.1%)

843/6863 (12.3%)

734/7748 (9.5%)

517/7490 (6.9%)

394/6269 (6.3%)

307/6067 (5.1%)

262/6486 (4.0%)

3957/46900 (8.4%)